12 Questions with Sam Dixey
Find out more about Sam Dixey, Head of Medical Affairs Innovation and Technology (MAIT) at LUCENT Biopharma.
Newsletters and Deep Dive digital magazine
Find out more about Sam Dixey, Head of Medical Affairs Innovation and Technology (MAIT) at LUCENT Biopharma.
At PPIC in Basel, pharma pricing experts discussed how policy changes and AI advances are altering the dynamics of pharmaceutical pricing and access.
The digital, supplier, CRO, and medtech services sectors continued to see a steady flow of leadership changes during the month of May.
In pharmaceutical development, conclusions are built on structured laboratory investigations and reproducible data, rather than simple classification.
Rolling out new systems is usually not the hardest part. The bigger shift lies in how engagement is structured and executed.
Editor's Picks
Newsletters and Deep Dive
digital magazine